Screener
Kestra Medical Technologies KMTS Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | Year Ended April 30, 2026 | Year Ended April 30, 2025 |
|---|---|---|
| Revenue | $95,126 | $59,815 |
| Cost of revenue | 46,263 | 35,605 |
| Gross profit | 48,863 | 24,210 |
| Operating expenses: | ||
| Research and development | 19,484 | 15,652 |
| Selling, general and administrative | 164,120 | 114,936 |
| Total operating expenses | 183,604 | 130,588 |
| Loss from operations | (134,741) | (106,378) |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's total cost of revenue?
- Kestra Medical Technologies (KMTS) reported total cost of revenue of $12.96M in Q1 2026.
- How has Kestra Medical Technologies's total cost of revenue changed year-over-year?
- Kestra Medical Technologies's total cost of revenue increased by 35.0% year-over-year, from $9.6M to $12.96M.
- What is the long-term trend for Kestra Medical Technologies's total cost of revenue?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's total cost of revenue has grown at a 29.8% compound annual growth rate (CAGR), from $27.45M to $46.26M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Kestra Medical Technologies's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude